Studies concerning the seroprevalence of toxoplasmosis among children, especially community-based studies, are very few. Indeed, the matter is complicated as the exposure to T. gondii in children might occur either prenatally (congenital) or postnatally (environmental). In congenital toxoplasmosis, there are 4 possible forms of clinical presentations: 1) symptomatic neonatal disease, in which chorioretinitis is the most common symptom, 2) mild to severe disease that manifests within the first month of life, 3) childhood or adolescent sequelae from previous undiagnosed infection, or 4) subclinical infection [9]. Thus, many of the apparently healthy children (AHC) might have acquired the disease congenitally but show no symptoms at the time of sample collection, or the infection, in the first place, is subclinical. The aims of the present study were; 1) to determine the seroprevalence of toxoplasmosis in AHC as well as visually and/or hearing disabled children (DC), 2) to estimate (hypothetically) the rate of congenital toxoplasmosis in DC compared to the rate in AHC, 3) to calculate and compare the incidence of acquired toxoplasmosis in AHC and DC, 4) to study the effects of age and gender on the seroprevalence and the incidence of toxoplasmosis in both AHC and DC.

Serum samples were collected from 2 children groups; 250 AHC (apparently healthy at the time of sampling who designated as "healthy") in which samples were randomly collected from different social communities in Taiz city, Yemen, and 120 DC (visually and/or hearing disabled children who were designated as "disabled" in which samples were collected from Sinnah Center for Disabled Children, the Association of Dumb and Deaf Children and the Yemeni-Swedish Hospital for Motherhood and Childhood. All members of this disabled group were either partially sighted, or completely blind or blind and deaf at the time of collecting samples. Samples were collected twice along a period of 12 months (from August 2006 to August 2007). The age range in both groups was 1-14 years for both genders, and accordingly, each main group was subdivided into 3 subgroups; less than 5 years, 5 to 10 years, and 10 to 14 years. A Toxo-latex diagnostic kit from BIOKIT (S.A, Barcelona, Spain) was used for serology in this study. The test is a qualitative one in which the results were interpreted as positive when agglutination was evident and negative when agglutination was not seen. According to the manufacturer's instruction for BIOKIT, the sensitivity, specificity, PPV, and NPV of the test were 100%, 84.2-95.8%, 91.2-99.4%, and 92.0-100%, respectively. Data were coded and entered on the computer using the MINITAB (version 12.1) statistical program. Then, association between different variables was calculated by logistic regression. The dependent variable was the stable infection (infected, seropositive/none infected, and seronegative); all other variables were considered independent.

The results showed that the seroprevalence of toxoplasmosis among DC was higher (32.5%) in comparison to that among AHC (16.0%), the difference being statistically significant (P < 0.001). The gender effects on the prevalence within the members of the same group (AHC) was also statistically significant (P < 0.05) as the rate was higher among females (18.3%) compared to males (13.8%). A similar result was noticed among the members of DC group (Table 1). According to the age, the rate was proportionally increased in both groups (Table 2). The age-related prevalence was higher in DC group than in AHC group. Table 3 shows the incidence rate of seropositivity for toxoplasmosis among AHC and DC groups during 1 year period. It is obvious that this rate was higher (4.2%) among DC group compared to AHC group (2.4%) with a high statistical significance (P = 0.005) (Table 3).

The present study is the first in Yemen for estimating the seroprevalence of toxoplasmosis among AHC as well as DC. The higher seroprevalence was noticed among DC group compared to AHC group. Such results were expected for 3 simple reasons. First, the higher rate of toxoplasmosis among DC group is likely to have been originated from 2 different sources of exposures including prenatal congenital and postnatal environmental acquisition. In spite of being not the only cause, congenital toxoplasmosis is considered as one of the most important etiologies of visual and hearing disabilities that can develop during the first few years of life. Accordingly, the elevation of the seroprevalence among children with visual and hearing disabilities compared to AHC is presumed to be due to mostly congenital toxoplasmosis rather than acquisition of the disease postnatally. Similar results were reported in Norway, Korea, and Poland [10-12]. The second probable reason for the elevation of the seroprevalence among DC could be the lack of family care for this group compared to AHC as many of these DC are inmates in these centers and at higher exposure rate for the disease risk factors. The third reason could be associated with the immunological status of DC, which, in most occasions, is weak, and may play a role in predisposition for postnatal environmental acquisition of toxoplasmosis. The 16% of Toxoplasma seropositivity among AHC in this study was in an inconsistency or only partial consistency with the results of other studies as those conducted in Brazil (32.4%), Basra, Iraq (9.1-41.4%), and 12.8% in Dublin, UK [13-15]. Indeed, the seroprevalence is highly variable among children in different regions of the world that follows many risk factors which were not investigated in this study.

Usually, it is not common to detect a significant difference of seroprevalence between different sexes [16]. However, there were a few studies that pointed out that this rate is higher either in males [17] or females [18]. In the present study, the seroprevalence of toxoplasmosis was higher in girls than boys for both AHC and DC groups. The association between sexes and seropositivity was evident (r = 0.125; P = 0.016). This could be due a different exposure rate to the possible risk factors which were not investigated in this study.

The present study suggests that seropositivity increases in accordance with the age of the children (r = 0.176, P = 0.022). These results might reflect the overlapping status between the congenital toxoplasmosis and the postnatally acquired toxoplasmosis for DC. On the other hand, the natural history of cumulative acquisition of toxoplasmosis which is proportional to the increasing time of exposure to the infective stages of T. gondii might explain the increasing seroprevalence rate of toxoplasmosis with the age among AHC. Similar results were reported by others [13-15]. An annual incidence rate of 2.4% among AHC group, compared to 4.2% among DC group with a high statistical significance (P = 0.005) confirms the results and conclusions of the prevalence rate that were discussed above in this manuscript. To the best of our knowledge, this study was the first in comparing such parameters in toxoplasmosis.